Skip to content

Implementing IntelliCare in Collaborative Care: A Quality Improvement Evaluation

Implementing IntelliCare in Collaborative Care: A Quality Improvement Evaluation

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04499729
Enrollment
318
Registered
2020-08-05
Start date
2019-12-01
Completion date
2021-05-01
Last updated
2021-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Brief summary

The overarching aim of the proposed project is to conduct a pragmatic, quality improvement evaluation of the IntelliCare Platform for improving processes of care in the Rush Collaborative Care program, and improving patient population depression outcomes, to determine the long-term utility of IntelliCare for Rush.

Detailed description

This study is a pragmatic, system-wide rollout quality improvement evaluation design displayed in Figure 1. The Rush IRB has waived consent for this quality improvement trial. Data from the EHR will be used beginning December 1, 2019. The first care manager (CM) will begin enrolling patients into IntelliCare in September, 2020. Additional CMs will begin using IntelliCare at approximately 3 month intervals. In September 2021, support for IntelliCare from the evaluation team will be withdrawn, to examine the sustainability of the IntelliCare Platform. Patients Data from all patients, aged 18 or older, enrolled collaborative care from December 1, 2019 through August 31, 2022 will be used to evaluate the IntelliCare service. All CCT patients who are 18 or older, and have a smartphone will be offered enrollment.

Interventions

IntelliCare provides self management and collects symptom self-report data. Symptom severity scores are displayed to the care manager, allowing them to manage the patient's care. The app also provides a secure messaging service for communication between the care manager and the patient.

BEHAVIORALTreatment as Usual (TAU)

Treatment as usual in the Rush Collaborative Care service

Sponsors

Rush University Medical Center
CollaboratorOTHER
Adaptive Health, Inc
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

We will utilize a pragmatic, system-wide rollout quality improvement evaluation design. Data from patients in the Rush Collaborative Care service will be used beginning Dec 1, 2019. The first care manager will begin offering IntelliCare as part of the collaborative care service in September, 2020, and one additional care manager will begin offering IntelliCare to patients every 3 months

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Enrolled in Rush Collaborative Care service * Owns a personal smartphone

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
DepressionUp to 20 MonthsPatient Health Questionnaire-9 (PHQ-9) assessment for depression
Number of assessmentsUp to 20 MonthsNumber of Patient Health Questionnaire (PHQ-9) assessments acquired in the EHR

Secondary

MeasureTime frameDescription
First to last assessmentUp to 20 MonthsTime from first to last PHQ-9

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026